Maternal-Fetal and Neonatal Endocrinology 2020
DOI: 10.1016/b978-0-12-814823-5.00022-2
|View full text |Cite
|
Sign up to set email alerts
|

Gestational Diabetes and Type 2 Diabetes During Pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 117 publications
0
9
0
Order By: Relevance
“…The important issues for the obstetricians in charge of patients with T2DM during pregnancy are the timing and type of delivery. The factors influencing this decision include, but are not limited to, fetal size, the presence of medical comorbidities, and placental insufficiency 16 . T2DM in pregnancy, per se, is associated with uteroplacental malperfusion, which can be presented as placental infarction, vasculopathy in deciduas, and earlier maturation of villi 17 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The important issues for the obstetricians in charge of patients with T2DM during pregnancy are the timing and type of delivery. The factors influencing this decision include, but are not limited to, fetal size, the presence of medical comorbidities, and placental insufficiency 16 . T2DM in pregnancy, per se, is associated with uteroplacental malperfusion, which can be presented as placental infarction, vasculopathy in deciduas, and earlier maturation of villi 17 .…”
Section: Introductionmentioning
confidence: 99%
“…The adequate timing and mode of delivery aim to reduce the rates of intrauterine death, which are higher among women with T2DM compared to women with other types of diabetes in pregnancy and healthy populations. Consequently, the most common timing for delivery of infants of mothers with T2DM is between 37+0 and 38+6 weeks, compared to the usually targeted timing of 40 weeks among women with GDM 16 .…”
Section: Introductionmentioning
confidence: 99%
“…Diagnosis is confirmed by two or more of: a fasting PG 5.3–6.9 mmol/L, 1-H PG ≥ 10.0 mmol/L, a 2-H PG 8.6–11.0 mmol/L, and a 3-H PG 7.8–11.0 mmol/L [ 9 ]. However, screening methods and diagnostic criteria have varied across years and governing bodies [ 10 ]. This has led to varying prevalence estimates and uncertainty for patients who may not have received GDM diagnosis in previous years[ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Diagnosis is con rmed by two or more of: a fasting PG 5.3-6.9 mmol/L, 1-H PG ≥10.0 mmol/L, a 2-H PG 8.6-11.0 mmol/L, and a 3-H PG 7.8-11.0 mmol/L (9). However, screening methods and diagnostic criteria have varied across years and governing bodies (10). This has led to varying prevalence estimates and uncertainty for patients who may not have received GDM diagnosis in previous years (11).…”
Section: Introductionmentioning
confidence: 99%